Pharma Foods International Co (TSE:2929) EV-to-EBIT : 4.53 (As of May. 16, 2024)

Pharma Foods International Co EV-to-EBIT Chart

Pharma Foods International Co Annual Data
	Trend	Jul14	Jul15	Jul16	Jul17	Jul18	Jul19	Jul20	Jul21	Jul22	Jul23
EV-to-EBIT		Get a 7-Day Free Trial					19.26	34.24	13.73	34.85	14.52

Pharma Foods International Co Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
EV-to-EBIT	Get a 7-Day Free Trial															-27.80	30.05	14.52	6.42	5.18

Competitive Comparison of Pharma Foods International Co's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Pharma Foods International Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharma Foods International Co's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharma Foods International Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Pharma Foods International Co's EV-to-EBIT falls into.

Pharma Foods International Co EV-to-EBIT Calculation

Pharma Foods International Co's EV-to-EBIT for today is calculated as:

Pharma Foods International Co's current Enterprise Value is 円27,384 Mil.
Pharma Foods International Co's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円6,048 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharma Foods International Co  (TSE:2929) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Pharma Foods International Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jan. 2024 is calculated as:

Pharma Foods International Co's Enterprise Value for the quarter that ended in Jan. 2024 was 円31,342 Mil.
Pharma Foods International Co's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円6,048 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharma Foods International Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Pharma Foods International Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharma Foods International Co (TSE:2929) Business Description